Amoy Diagnostics
IPOAmoyDx
Xiamen, China · Founded 2008
- Headquarters
- Xiamen
- Founded
- 2008
- Business Model
- B2B
- Website
- amoydiagnostics.com
- Last Round
- Series CJan 2015
- Rounds
- 3
About
Amoy Diagnostics develops molecular diagnostics for oncology precision medicine, including PCR, NGS, and IHC products.
Summary
Amoy Diagnostics is a Diagnostics company based in Xiamen, China, founded in 2008. Its most recent funding was a Series C round in Jan 2015. Investors include Qiming VP and OrbiMed.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2019
Sign up to see all 4 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Ginkgo Bioworks operates autonomous laboratories that use robotics to run experimental work, help...
Function Health offers annual lab testing and personalized health insights, helping members track...
Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...
LetsGetChecked provides at-home testing, virtual consultations, prescription fulfillment, and cli...
Population genomics and viral surveillance company enabling health systems and public health orga...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amoy-diagnostics"><img src="https://indexed.vc/api/badge/company/amoy-diagnostics" alt="Amoy Diagnostics on Indexed.vc" width="260" height="76" /></a>